| 1 |
30791232 | DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, SUZ12, and KRAS. | 2019 Apr |
2 |
| 2 |
31173259 | miR‑29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR‑29 regulation. | 2019 Aug |
1 |
| 3 |
27765932 | Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation. | 2016 Dec 13 |
1 |
| 4 |
26384351 | The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients. | 2015 Oct 20 |
1 |
| 5 |
24970385 | 5-aza-2'-deoxycytidine-mediated c-myc Down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia. | 2014 Jun |
1 |
| 6 |
25263941 | Gene body methylation can alter gene expression and is a therapeutic target in cancer. | 2014 Oct 13 |
1 |
| 7 |
23341364 | Decitabine represses translocated MYC oncogene in Burkitt lymphoma. | 2013 Apr |
5 |
| 8 |
22654424 | Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. | 2012 May 21 |
1 |
| 9 |
19179467 | Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine. | 2009 Apr 30 |
2 |
| 10 |
19623543 | Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells. | 2009 Nov 1 |
1 |
| 11 |
12970888 | Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines. | 2003 Sep |
1 |
| 12 |
7683359 | Effects of 5-aza-2'-deoxycytidine on differentiation and oncogene expression in the human monoblastic leukemia cell line U-937. | 1993 May |
1 |